Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/22486
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Petronijević, Jelena | - |
dc.contributor.author | Joksimović N. | - |
dc.contributor.author | Kostic, Marina | - |
dc.contributor.author | Divac, Vera | - |
dc.contributor.author | Janković, Nenad | - |
dc.date.accessioned | 2025-08-05T12:17:29Z | - |
dc.date.available | 2025-08-05T12:17:29Z | - |
dc.date.issued | 2018 | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/22486 | - |
dc.description.abstract | In order to investigate new potential therapeutically active agents, we investigated the biological properties of two small libraries of quinoxalinones and 3,4-dihydro-2(1H)-quinoxalinones (Fig. 1). The results obtained showed that compounds 5, 9–11 have good cytotoxic activity against HeLa cells where the lowest IC50 ǀalue ;ϭϬ.ϰϲ ± Ϭ.ϴϮ μM/ŵLͿ ǁas measured for compound 10. Additionally, the most active compounds (5, 9–11) showed much better selectivity for MRC-5 cells (up to 17.4) compared to cisplatin. In vitro evaluation of the iŶhiďitioŶ of the eŶzLJŵe α-glucosidase showed that compounds 10 and 11 exert significant iŶhiďitioŶ of the eŶzLJŵe at ϱϮ.ϱϰ ± Ϭ.Ϭϵ aŶd ϰϬ.Ϭϵ ± Ϭ.ϰϵ μM, ƌespeĐtiǀelLJ. | en_US |
dc.language.iso | en | en_US |
dc.rights | CC0 1.0 Universal | * |
dc.rights.uri | http://creativecommons.org/publicdomain/zero/1.0/ | * |
dc.subject | quinoxalinones | en_US |
dc.subject | 3,4-dihydro-2(1H)-quinoxalinones | en_US |
dc.subject | biological activity | en_US |
dc.title | Biological evaluation of the 3,4-dihydro-2(1H)-quinoxalinones and 3,4-dihydro-1,4-benzoxazin-2-ones | en_US |
dc.type | conferenceObject | en_US |
dc.description.version | Published | en_US |
dc.type.version | PublishedVersion | en_US |
dc.source.conference | 55th Meeting of the Serbian Chemical Society, 2018, Novi Sad, Serbia | en_US |
Appears in Collections: | Institute for Information Technologies, Kragujevac |
This item is licensed under a Creative Commons License